Hobart, Jeremy
181  results:
Search for persons X
?
3

Reconciling lesions, relapses and smouldering associated wo..:

Mistry, Niraj ; Hobart, Jeremy ; Rog, David...
Multiple Sclerosis and Related Disorders.  88 (2024)  - p. 105706 , 2024
 
?
4

A study of referral bias in NMOSD and MOGAD cohorts:

Leal Rato, Miguel ; Chen, Bo ; Francis, Anna...
Multiple Sclerosis and Related Disorders.  85 (2024)  - p. 105553 , 2024
 
?
9

Do clinical trials prepare to fail by failing to prepare? A..:

Hobart, Jeremy ; Chitnis, Tanuja ; Oh, Jiwon...
Multiple Sclerosis and Related Disorders.  76 (2023)  - p. 104788 , 2023
 
?
11

Timely intervention, monitoring and education MATTERS in MS..:

Hobart, Jeremy ; Butzkueven, Helmut ; Haartsen, Jodi...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  8 (2022)  3 - p. 205521732211240 , 2022
 
?
12

Evaluating the feasibility of a real world pharmacovigilanc..:

Dobson, Ruth ; Craner, Matthew ; Waddingham, Ed...
Multiple Sclerosis and Related Disorders.  63 (2022)  - p. 103894 , 2022
 
?
13

Factors contributing to CSF NfL reduction over time in thos..:

Smets, Ide ; Holden, David ; Bianchi, Lucia...
Multiple Sclerosis and Related Disorders.  57 (2022)  - p. 103409 , 2022
 
?
14

The agenda of the global patient reported outcomes for mult..:

Zaratin, Paola ; Vermersch, Patrick ; Amato, Maria Pia...
Multiple Sclerosis and Related Disorders.  61 (2022)  - p. 103757 , 2022
 
?
15

Patient-reported outcome measures in MS: Do development pro..:

Bharadia, Trishna ; Vandercappellen, Jo ; Chitnis, Tanuja...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  8 (2022)  2 - p. 205521732211056 , 2022
 
1-15